Rémy Diesnis

Dr. Rémy Diesnis

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2025 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
GPGuillaume Pouessel
Guillaume Pouessel
CEClaire Egea
Claire Egea
ADAmandine Divaret-Chauveau
Amandine Divaret-Chauveau
PBPascale Beaumont
Pascale Beaumont
EBEléna Bradatan
Eléna Bradatan
DSDominique Sabouraud‐Leclerc
Dominique Sabouraud‐Leclerc

21 November 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
ECEmma Chambe
Emma Chambe
PBPerrine Bortolotti
Perrine Bortolotti
RDRémy Diesnis
Rémy Diesnis
CLCaroline Laurans
Caroline Laurans
RHRozenn Héquette-Ruz
Rozenn Héquette-Ruz
AMAgnès Meybeck
Agnès Meybeck
Pulmonary multiplex polymerase chain reaction (m-PCR) allows rapid pathogen detection. We aimed to assess its impact on initial antibiotic prescriptions in ventilated patients with suspected pneumonia. Between November 2020 and March 2022,ventilated patients with suspected pneumonia hospitalized in our ICU who benefited from respiratory sampling simultaneously tested using conventional microbiological methods and m-PCR were included. The proportion of appropriate changes in the initial antibiotic therapy following m-PCR results was assessed. We analyzed 104 clinical samples. Of the 47 negative m-PCR results, 16 (34%) led to an appropriate antibiotic strategy: 8 cessationsand 8 lack of initiation. Of the 57 positive m-PCR results, 51 (89%) resulted in an appropriate antibiotic strategy: 33 initiations, 2 optimizations, and 9 de-escalations. In the multivariate analysis, a positive m-PCR was associated with an appropriate antibiotic change (OR: 96.60; IC95% [9.72; 960.20], p < 0.001). A higher SAPS II score was negatively associated with an appropriate antibiotic change (OR: 0.96; IC95% [0.931; 0.997], p = 0.034). In our cohort, a positive m-PCR allowed for early initiation or adjustment of antibiotic therapy in almost 90% of cases. A negative m-PCR spared antibiotic use in onethird of cases. The impact of m-PCR results was reduced in the most severe patients.

31 May 2025 in Toxics
Verified
Journal Article
Open access
PDF file
GGGuillaume Grzych
Guillaume Grzych
RDRémy Diesnis
Rémy Diesnis
TDThierry Dupré
Thierry Dupré
JNJean Paul Niguet
Jean Paul Niguet
EGEmeline Gernez
Emeline Gernez
ACAnthony CHAUVIN
Anthony CHAUVIN
Nitrous oxide (N2O) was originally used for medical and industrial purposes, but its recreational use has dramatically increased, raising a major global public health concern. Chronic inhalation is associated with neurological, metabolic, and psychiatric complications, as well as addiction. To address these challenges, the PROTOSIDE network was developed to provide a multidisciplinary approach to management and prevention. This initiative relies on competence centers integrating specialists in emergency medicine, neurology, clinical biochemistry, and addiction medicine. PROTOSIDE aims to standardize diagnostic protocols, optimize patient care pathways, and strengthen addictovigilance. A strong emphasis is placed on prevention, including awareness campaigns and collaboration with healthcare professionals and educators. By facilitating access to advanced biochemical analyses (homocysteine, methylmalonic acid) and promoting international guidelines, PROTOSIDE represents an innovative model for a global response to N2O misuse. This integrated approach enhances clinical management, reduces complications, and harmonizes public health strategies.

20 December 2023 in European Journal of Neurology
Verified
Journal Article
Open access
EGEmeline Gernez
Emeline Gernez
ALAngèle Lucas
Angèle Lucas
JNJean‐Paul Niguet
Jean‐Paul Niguet
ABAnas Bennis
Anas Bennis
RDRémy Diesnis
Rémy Diesnis
GGGuillaume Grzych
Guillaume Grzych

2 February 2022 in Research Square
Verified
Preprint
Open access
PDF file
CMConstance Michiels
Constance Michiels
FOFrançois Outteryck
François Outteryck
PLPerrine Libert
Perrine Libert
KBKarine Bauley
Karine Bauley
CGCarole Godesence
Carole Godesence
RDRémy Diesnis
Rémy Diesnis
Background: As the population ages, the prevalence of atrial fibrillation (AF) is increasing. This leads to significant healthcare resource use – mainly the cost of hospitalization. Using guidelines, we built the Ambulatory Care Score for Atrial Fibrillation (ACSAF) for application in emergency departments (EDs) that lack a cardiologist. The primary objective of the present study was to validate the ACSAF for the triage of new-onset AF (NOAF) by comparison with the cardiologist’s opinion.Methods: This single-centre, prospective, observational, comparative study was performed at a general hospital between November 2018 and October 2019. All adult patients with NOAF were included. Patients with a systolic blood pressure 180 bpm were excluded. The ACSAF was calculated by an ED physician in blind to the cardiologist’s opinion. The primary outcome was the mean difference in the ACSAF between ambulatory care group and the hospital care group. A receiver operating characteristic (ROC) curve was plotted to determine the optimal cut-off for the ACSAF. Results: 81 patients with NOAF (42 men (51.9%); mean age: 69 ±16 years old) were included in the study. The mean ACSAF was higher in the hospital care group (2.16 ±1.05) than in the ambulatory care group (1.03 ±0.97; p<0.0001). The optimal ACSAF cut-off was 2, giving a sensitivity [95% confidence interval] of 71.4%[57.1-83.7] and a specificity of 81.2%[68.8-93.8]. Discussion & Conclusion: The ACSAF enables ED physicians to decide on the triage of NOAF in the absence of a cardiologist’s opinion.Trial registration: ANSM (French Drug Administration) : ID RCB 2018-A01800-55 French National Data Protection Commission (Commission nationale de l'informatique et des libertés (Paris, France); reference: MRC-003 2197970, June 2nd, 2018)

24 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
RDRémy Diesnis
Rémy Diesnis
JLJean-Baptiste Lezy
Jean-Baptiste Lezy
JWJeremy Wallart
Jeremy Wallart
VPVincent Pegoraro
Vincent Pegoraro
GBGrégory Bertolotti
Grégory Bertolotti
EWEric Wiel
Eric Wiel
Objective: In 2020, the emergence of Covid-19, rapidly evolves into a global pandemic. The government has put in place measures and recommendations to limit the spread of the virus. Some studies have focused on the effects of lockdown and social distancing on the Emergency Department (ED) attendance. Our hypothesis is that the number of visits vary with the incidence. Methods: We designed a multicentric, observational, retrospective study between May 13, 2020, and May 3, 2021. All patients over 18 years old from 8 ED were included, excluding inter-hospital transfers. Demographic variables, reasons for use, discharge diagnosis and destination were extracted from electronic files. A visit was considered covid-like (CL) if one of the reasons for use was fever, cough or dyspnea. Reasons for use and discharge diagnosis were grouped by specialty for subgroup analysis. We compared the number of entries according to the Covid incidence rate using Spearman’s correlation coefficient adjusted to the governmental measures. Results: 237,888 ED visits of patients of 49 years with 49.3% of men were enrolled. The correlation between ED visits and the Covid-19 incidence rate adjusted for governmental measures is 0.22 (p=0.131). The correlation between visits and the incidence rate was 0.24 (p=0.454) during lockdown, 0.157 (p=0.467) during unlockdown, and 0.832 (p<0.0001) during the curfew. The correlation between attendance and the Covid-19 incidence rate was 0.83 (p<0.0001) for CL reasons compared to 0.02 (p=0.880) for non-Covid-like (NCL) reasons. Only respiratory and miscellaneous reasons, where CL reasons are classified (dyspnea, cough and fever), have a significant to moderate correlation (respectively r=0,86, p<0,0001 and r=0,53, p<0,0001). Only diagnoses of infectious and respiratory pathologies have a moderate to significant correlation in relation to the incidence rate of Covid-19 (respectively r=0,68, p<0,0001 and r=0,91, p<0,0001) with an increase in hospitalizations in ward units (r=0,69, p<0,0001). There is any correlation between Covid-19 incidence rate and intensive care units’ admission. Conclusion: Our study does not highlight a link between the incidence of Covid-19 and global ED visits or for NCL use. The incidence rate does not seem to be a good indicator for predicting ED visits.